Jason B. Muhitch

Roswell Park Comprehensive Cancer Center — United States

Medicine · Health Sciences

15h-index1.5kcitations94works2.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(50), Renal cell carcinoma treatment(31), Colorectal Cancer Treatments and Studies(22), Immunotherapy and Immune Responses(19), CAR-T cell therapy research(17)

Publications94 total

32Interplay of Tumor-Intrinsic and microenvironmental gene expression predicts immune checkpoint blockade response in metastatic renal cell carcinoma
The Oncologist·2025Open Access
53Microenvironmental characteristics of disease relapse after nephrectomy in clear cell renal cell carcinoma
The Oncologist·2025Open Access
Comprehensive tumor-immune profiling reveals mediators of paradoxical immune sensitivity in sarcomatoid renal cell carcinoma
Cancer Cell·2025· 4 citedOpen Access
Biological and Clinical Insight into the Prevention and Management of Metastatic Renal Cell Carcinoma with a Sarcomatoid Component
European Urology Focus·2025· 2 cited
Integrating IL-12 mRNA nanotechnology with SBRT eliminates T cell exhaustion in preclinical models of pancreatic cancer
Molecular Therapy — Nucleic Acids·2024· 10 citedOpen Access
25 Enrichment of tertiary lymphoid structures provides novel insight into mediators of anti-tumor immune activity in sarcomatoid renal cell carcinoma
The Oncologist·2024Open Access
26 Applying single cell RNA sequencing of sarcomatoid renal cell carcinoma for the development of a novel transcriptomic biomarker to predict immunotherapy response
The Oncologist·2024Open Access
MP36-12 CLASSIFICATION BY SARCOMATOID FEATURE ABUNDANCE IN RENAL CELL CARCINOMA REVEALS DIFFERENTIAL PATIENT OUTCOMES AND TRANSCRIPTOMIC FEATURES
The Journal of Urology·2024
Stratification of Patients with Renal Cell Carcinoma by the Abundance of Sarcomatoid Features Reveals Differences in Survival and the Underlying Pathobiology
European Urology Oncology·2024· 8 citedOpen Access
A Bacterial and Ganglioside-based Nanoparticle Initiates Reprogramming of Macrophages and Promotes Antitumor Phenotypes
The Journal of Immunology·2023· 3 cited
Local Delivery of SBRT and IL12 by mRNA Technology Overcomes Immunosuppressive Barriers to Eliminate Pancreatic Cancer
2023· 3 citedOpen Access
Final results from a phase II trial of CIMAvax-EGF and nivolumab as second-line (2L) therapy after platinum-based chemotherapy in advanced non-small cell lung cancer (NSCLC).
Journal of Clinical Oncology·2023· 7 cited
Tumor and immune remodeling following radiotherapy in human renal cell carcinoma
Journal for ImmunoTherapy of Cancer·2023· 31 citedOpen Access
Figure S4 from A Pilot Study of Stereotactic Body Radiation Therapy Combined with Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma
2023Open Access
Data from Phase Ib/II Study of Cetuximab plus Pembrolizumab in Patients with Advanced RAS Wild-Type Colorectal Cancer
2023Open Access
Supplementary Figure 1 from Phase Ib/II Study of Cetuximab plus Pembrolizumab in Patients with Advanced RAS Wild-Type Colorectal Cancer
2023Open Access
Data from Phase Ib/II Study of Cetuximab plus Pembrolizumab in Patients with Advanced RAS Wild-Type Colorectal Cancer
2023Open Access
Supplementary Figure 2 from Phase Ib/II Study of Cetuximab plus Pembrolizumab in Patients with Advanced RAS Wild-Type Colorectal Cancer
2023Open Access
Supplementary Table 3 from Phase Ib/II Study of Cetuximab plus Pembrolizumab in Patients with Advanced RAS Wild-Type Colorectal Cancer
2023Open Access
Supplementary Figure 3 from Phase Ib/II Study of Cetuximab plus Pembrolizumab in Patients with Advanced RAS Wild-Type Colorectal Cancer
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Scott I. Abrams(24), Sharon S. Evans(14), Kristopher Attwood(13), Hans Minderman(12), Thomas Schwaab(11), Christos Fountzilas(11), Daniel T. Fisher(10), Alan D. Hutson(10), Orla Maguire(10), Paweł Kaliński(10), Joel Saltzman(9), David L. Bajor(9), Renuka Iyer(9), Patrick M. Boland(9), Joseph J. Skitzki(8), Sarbajit Mukherjee(8), Anurag K. Singh(7), Karen A. Hicks(7), Agnieszka K. Witkiewicz(7), Erik S. Knudsen(7)